Contract 36E79723D0004
Radha Pharmaceuticals Inc · Department Of Veterans Affairs · March 9, 2026
Radha Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on March 9, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 9, 2026. If all options are exercised, the contract could reach $15.98 million.
Contract details
- PIID
- 36E79723D0004
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 9, 2026
- Latest action
- March 9, 2026
Description
THIS MODIFICATION IS ISSUED TO EXERCISE THE 3RD OPTION YEAR FOR CLOPIDOGREL BISULFATE TABLETS UNDER CONTRACT 36E79723D0004 WITH RADHA PHARMACEUTICALS INC. FOR THE PERIOD OF 04/15/2026 TO 04/14/2027.
Modification timeline
-
March 9, 2026Mod P00005 · Exercise An Option$0
-
March 9, 2026Mod P00005$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79723D0004?
Contract 36E79723D0004 is a federal contract awarded to Radha Pharmaceuticals Inc by Department Of Veterans Affairs on March 9, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36E79723D0004?
Radha Pharmaceuticals Inc won contract 36E79723D0004 from Department Of Veterans Affairs.
How much is contract 36E79723D0004 worth?
Contract 36E79723D0004 has obligated $0 to date but carries a potential ceiling of $15.98 million if fully funded and all options are exercised.